Avid Bioservices Announces Termination of Stockholder Rights Plan

Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019

Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors

Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers

Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices to Participate at BIO International Convention 2019